[1] When to Seek Medical Advice Seek immediate medical attention (call 999 or attend A&E) if you experience: Signs of severe allergic reaction (anaphylaxis) : difficulty breathing, swelling of face/lips/tongue/throat, severe rash or hives, rapid pulse, dizziness or fainting Contact NHS 111 or seek urgent GP advice if you develop: Severe, persistent abdominal pain (possibly radiating to the back), with or without vomiting, which may indicate pancreatitis [1] Severe upper right abdominal pain, fever, or yellowing of skin or eyes (jaundice), which may suggest gallbladder problems Severe or persistent gastrointestinal symptoms preventing adequate fluid or food intake Signs of dehydration (dark urine, dizziness, reduced urination, extreme thirst) Contact your GP if you notice: Persistent injection site reactions lasting more than one week Signs of infection at injection sites (increasing warmth, spreading redness, pus, fever) Recurrent hypoglycaemia if taking diabetes medications Unexplained visual changes or severe headaches A lump or swelling in the neck, persistent hoarseness, difficulty swallowing, or shortness of breath Symptoms of depression or suicidal thoughts (rare but reported) Routine follow-up with your prescribing clinician is essential for monitoring treatment response, managing side effects, and adjusting doses appropriately

After 72 weeks of treatment, participants reported higher rates of histological resolution of steatohepatitis and improvement in liver fibrosis those who received placebo, alongside substantial weight reduction [50, 51]
People who converted vague aims into one measurable behavior, for example, walking 30 minutes five times weekly for four weeks, were far more likely to keep exercising when their appetite changed
SeekPeptides provides comprehensive comparison tools and protocols to help you make informed decisions about your GLP-1 medication
The intervention arm included semaglutide
Both 200 mg and 400 mg doses showed similar lean mass preservation (50.8% vs 51.3%)